PTEN, a candidate tumor suppressor gene located at chromosome 10q23.3, has
been shown to be mutated in similar to 40% of endometrial cancers. Such mut
ations have also been identified in endometrial hyperplasia, indicating tha
t inactivation of the PTEN tumor suppressor gene is an early event in the g
enesis of some endometrial cancers. In this study, we have extended the ana
lysis of PTEN in gynecological cancer to include adenocarcinoma of the ceni
x and vulvar carcinomas. Microdissected tissue (including normal tissues),
preneoplastic, and neoplastic lesions were analyzed from 9 patients with ce
rvical cancer and 10 patients with vulvar cancer. Only 1 cervical adenocarc
inoma displayed a PTEN mutation. In contrast, five of eight vulvar carcinom
as studied harbored PTEN mutations. Alterations were identified in carcinom
a in situ as web as squamous cell carcinoma of the vulva. In two patients,
PTEN mutations were identified in mucosal regions with mild or focal dyspla
sia, These results suggest that PTEN is frequently altered in vulvar carcin
omas and can be found associated with early dysplastic changes in vulvar mu
cosa.